---
document_datetime: 2023-09-21 17:39:25
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/irbesartan-hydrochlorothiazide-bms-epar-all-authorised-presentations_en.pdf
document_name: irbesartan-hydrochlorothiazide-bms-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.9057461
conversion_datetime: 2025-12-19 03:16:46.86072
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name                                | Strength              | Pharmaceutical Form   | Route of administration   | Packaging              | Package size   |
|-----------------|----------------------------------------------|-----------------------|-----------------------|---------------------------|------------------------|----------------|
| EU/1/06/369/001 | Irbesartan Hydrochlorothiazide BMS           | 150mg/12.5mg          | Tablet                | Oral use                  | Blister (PVC/PVDC/Alu) | 14 tablets     |
| EU/1/06/369/002 | Irbesartan Hydrochlorothiazide BMS           | 150mg/12.5mg          | Tablet                | Oral use                  | Blister (PVC/PVDC/Alu) | 28 tablets     |
| EU/1/06/369/003 | Irbesartan Hydrochlorothiazide BMS           | 150mg/12.5mg          | Tablet                | Oral use authorised       | Blister (PVC/PVDC/Alu) | 56 tablets     |
| EU/1/06/369/004 | Irbesartan Hydrochlorothiazide BMS           | 150mg/12.5mg          | Tablet                | Oral use                  | Blister (PVC/PVDC/Alu) | 56 x 1 tablets |
| EU/1/06/369/005 | Irbesartan Hydrochlorothiazide BMS           | 150mg/12.5mg          | Tablet                | Oral use                  | Blister (PVC/PVDC/Alu) | 98 tablets     |
| EU/1/06/369/006 | Irbesartan Hydrochlorothiazide BMS           | 300mg/12.5 mg         | Tablet                | Oral use                  | Blister (PVC/PVDC/Alu) | 14 tablets     |
| EU/1/06/369/007 | Irbesartan Hydrochlorothiazide BMS           | 300mg/12.5 mg         | Tablet longer         | Oral use                  | Blister (PVC/PVDC/Alu) | 28 tablets     |
| EU/1/06/369/008 | Irbesartan Hydrochlorothiazide BMS           | 300mg/12.5 mg         | Tablet no             | Oral use                  | Blister (PVC/PVDC/Alu) | 56 tablets     |
| EU/1/06/369/009 | Irbesartan Hydrochlorothiazide BMS           | 300mg/12.5 mg         | Tablet                | Oral use                  | Blister (PVC/PVDC/Alu) | 56 x 1 tablets |
| EU/1/06/369/010 | Irbesartan Hydrochlorothiazide BMS           | 300mg/12.5 mg product | Tablet                | Oral use                  | Blister (PVC/PVDC/Alu) | 98 tablets     |
| EU/1/06/369/011 | Irbesartan Hydrochlorothiazide BMS           | 150mg/12.5mg          | Film-coated tablets   | Oral use                  | Blister (PVC/PVDC/Alu) | 14 tablets     |
| EU/1/06/369/012 | Irbesartan Hydrochlorothiazide BMS           | 150mg/12.5mg          | Film-coated tablets   | Oral use                  | Blister (PVC/PVDC/Alu) | 28 tablets     |
| EU/1/06/369/013 | Irbesartan Hydrochlorothiazide BMS           | 150mg/12.5mg          | Film-coated tablets   | Oral use                  | Blister (PVC/PVDC/Alu) | 56 tablets     |
| EU/1/06/369/014 | Irbesartan Hydrochlorothiazide BMS           | 150mg/12.5mg          | Film-coated tablets   | Oral use                  | Blister (PVC/PVDC/Alu) | 56 x 1 tablets |
| EU/1/06/369/015 | Irbesartan Hydrochlorothiazide BMS Medicinal | 150mg/12.5mg          | Film-coated tablets   | Oral use                  | Blister (PVC/PVDC/Alu) | 84 tablets     |
| EU/1/06/369/016 | Irbesartan Hydrochlorothiazide BMS           | 150mg/12.5mg          | Film-coated tablets   | Oral use                  | Blister (PVC/PVDC/Alu) | 98 tablets     |

<div style=\"page-break-after: always\"></div>

EU/1/06/369/017 EU/1/06/369/018 EU/1/06/369/019 EU/1/06/369/020 EU/1/06/369/021 EU/1/06/369/022 EU/1/06/369/023 EU/1/06/369/024 EU/1/06/369/025 EU/1/06/369/026 EU/1/06/369/027 EU/1/06/369/028

Irbesartan Hydrochlorothiazide BMS Irbesartan Hydrochlorothiazide BMS Irbesartan Hydrochlorothiazide BMS Irbesartan Hydrochlorothiazide BMS Irbesartan Hydrochlorothiazide BMS Irbesartan Hydrochlorothiazide BMS Irbesartan Hydrochlorothiazide BMS Irbesartan Hydrochlorothiazide BMS Irbesartan Hydrochlorothiazide BMS Irbesartan Hydrochlorothiazide BMS Irbesartan Hydrochlorothiazide BMS Irbesartan Hydrochlorothiazide BMS

300mg/12.5 mg

300mg/12.5 mg

300mg/12.5 mg

300mg/12.5 mg

300mg/12.5 mg

300mg/12.5 mg

300mg/25 mg

300mg/25 mg

300mg/25 mg

300mg/25 mg

300mg/25 mg

300mg/25 mg

Film-coated tablets

Film-coated tablets

Film-coated tablets

Film-coated tablets

Film-coated tablets

Film-coated tablets

Film-coated tablets

Film-coated tablets

Film-coated tablets

Film-coated tablets

Film-coated tablets

Film-coated tablets

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Medicinal product no longer authorised

Blister (PVC/PVDC/Alu) Blister (PVC/PVDC/Alu) Blister (PVC/PVDC/Alu) Blister (PVC/PVDC/Alu) Blister (PVC/PVDC/Alu) Blister (PVC/PVDC/Alu) Blister (PVC/PVDC/Alu) Blister (PVC/PVDC/Alu) Blister (PVC/PVDC/Alu) Blister (PVC/PVDC/Alu) Blister (PVC/PVDC/Alu) Blister (PVC/PVDC/Alu)

14 tablets 28 tablets 56 tablets 56 x 1 tablets 84 tablets 98 tablets 14 tablets 28 tablets 56 tablets 56 x 1 tablets 84 tablets 98 tablets